Justices Ask DOJ to Weigh In on Teva’s Drug Labeling Fight

The Supreme Court on Monday asked the US solicitor general to weigh in on a long-running generic drug labeling fight that could affect how lower-cost medications come to market.

Teva Pharmaceuticals wants the high court to review a case over a common practice known as “skinny labeling,” which involves leaving a name-brand drug’s patented uses off of a generic label to avoid infringement liability. Teva argued the lower court’s ruling threatens to wreak havoc on competition.

The dispute has already gone through the US Court of Appeals for the Federal Circuit twice. The appeals court ruled that Teva’s label on ...